Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes.
Sharma, M D
Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes. [electronic resource] - Diabetes, obesity & metabolism Jul 2015 - 616-21 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1463-1326
10.1111/dom.12451 doi
Blood Glucose--drug effects
Diabetes Mellitus, Type 2--blood
Dipeptidyl-Peptidase IV Inhibitors--therapeutic use
Drug Therapy, Combination
Glycated Hemoglobin--drug effects
Humans
Sodium-Glucose Transporter 2 Inhibitors
Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes. [electronic resource] - Diabetes, obesity & metabolism Jul 2015 - 616-21 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1463-1326
10.1111/dom.12451 doi
Blood Glucose--drug effects
Diabetes Mellitus, Type 2--blood
Dipeptidyl-Peptidase IV Inhibitors--therapeutic use
Drug Therapy, Combination
Glycated Hemoglobin--drug effects
Humans
Sodium-Glucose Transporter 2 Inhibitors